RT Journal Article SR Electronic T1 Drug-Resistant Variants of Escherichia coliThymidylate Synthase: Effects of Substitutions at Pro-254 JF Molecular Pharmacology JO Mol Pharmacol FD American Society for Pharmacology and Experimental Therapeutics SP 359 OP 366 VO 57 IS 2 A1 Fantz, Corinne A1 Shaw, David A1 Jennings, William A1 Forsthoefel, Antonia A1 Kitchens, Maria A1 Phan, Jason A1 Minor, Wladek A1 Lebioda, Lukasz A1 Berger, Franklin G. A1 Spencer, H. Trent YR 2000 UL http://molpharm.aspetjournals.org/content/57/2/359.abstract AB Drug-resistant variants of thymidylate synthase (TS) can potentially be used in gene therapy applications to decrease the myelosuppressive side effects of TS-directed anticancer agents or to select genetically modified cells in vivo. Mutations of proline 303 of human TS confer resistance to TS-directed fluoropyrimidines and antifolates (Kitchens et al., 1999). We generated the corresponding variants inEscherichia coli TS (ecTS), position 254, to better understand the mechanism by which mutations at this residue confer resistance. In addition, because ecTS is intrinsically resistant to several antifolates when compared with human TS, we suspected that greater resistance could be achieved with the bacterial enzyme. The P254L enzyme conferred >100-fold resistance to both raltitrexed and 5-fluoro-2′-deoxyuridine (FdUrd) compared with wild-type ecTS. Four additional mutants (P254F, P254S, P254G, and P254D), each of which complemented growth of a TS-deficient cell line, were generated, isolated, and characterized. Steady-state values ofK m for dUMP andk cat were not substantially different among the variants and were comparable with the wild-type values, butK m for methylenetetrahydrofolate (CH2H4PteGlu) was >10-fold higher for P254D. Values of k on andk off for nucleotide binding, which were obtained by stopped-flow spectroscopy, were virtually unchanged among the mutants. Drastic differences were observed for CH2H4PteGlu binding, withK d values >15-fold higher than observed with the wild-type enzyme; surprisingly, the proposed isomerization reaction that is very evident for the wild-type enzyme is not observed with P254S. The decrease in affinity for CH2H4PteGlu correlates well withK i values obtained for three TS-directed inhibitors. These results show that mutations at Pro-254 specifically affect the initial binding interactions between enzyme and cofactor and also alter the ability of the mutant enzymes to undergo conformational changes that occur on ternary complex formation. The crystal structure of P254S was determined at 1.5 Å resolution and is the most precise structure of TS available. When compared with wild-type TS, the structure shows local conformational changes affecting mostly Asp-253; its carbonyl is rotated approximately 40°, and the side chain forms an ion pair with Arg-225. The American Society for Pharmacology and Experimental Therapeutics